Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2025845
下载链接
链接失效反馈官方服务：
资源简介：
- Assess the safety and tolerance of a weekly MEDI522 regimen in patients with irinotecan-refractory advanced CRC or other solid tumors refractory to standard therapy.
创建时间：
2001-07-15
